CN106749439B - Fucoidan oligosaccharide and the preparation method and application thereof - Google Patents

Fucoidan oligosaccharide and the preparation method and application thereof Download PDF

Info

Publication number
CN106749439B
CN106749439B CN201611258163.5A CN201611258163A CN106749439B CN 106749439 B CN106749439 B CN 106749439B CN 201611258163 A CN201611258163 A CN 201611258163A CN 106749439 B CN106749439 B CN 106749439B
Authority
CN
China
Prior art keywords
preparation
oligosaccharide
fucoidan
residue
fucoidan oligosaccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201611258163.5A
Other languages
Chinese (zh)
Other versions
CN106749439A (en
Inventor
米哈伊尔·库萨金
刘昌衡
张绵松
袁文鹏
贾爱荣
赵佩佩
张玉
史亚萍
夏雪奎
阿提姆·西尔琴科
安东·瑞森
阿纳托利·卡利诺夫斯卡
斯维特拉娜·厄玛克娃
塔吉亚娜·兹维亚金特斯娃
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pacific Bioorganic Chemical Research Institute Of Far Eastern Branch Of Russian Academy Of Science
Biology Institute of Shandong Academy of Sciences
Original Assignee
Pacific Bioorganic Chemical Research Institute Of Far Eastern Branch Of Russian Academy Of Science
Biology Institute of Shandong Academy of Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pacific Bioorganic Chemical Research Institute Of Far Eastern Branch Of Russian Academy Of Science, Biology Institute of Shandong Academy of Sciences filed Critical Pacific Bioorganic Chemical Research Institute Of Far Eastern Branch Of Russian Academy Of Science
Priority to CN201611258163.5A priority Critical patent/CN106749439B/en
Publication of CN106749439A publication Critical patent/CN106749439A/en
Application granted granted Critical
Publication of CN106749439B publication Critical patent/CN106749439B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/04Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/14Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

The invention discloses fucoidan oligosaccharides and the preparation method and application thereof, and including the chain being connected in sequence by four fucosyl residues, by 1 → 3 and 1 → 4 chemical combination alternately occurs for fucosyl residues, and sulfate is distributed in the C of the second saccharide residue2And C3On and third saccharide residue C2On.The quantity of fucosyl residues (fixed structure) in fucoidan oligosaccharide provided in the present invention is 4 or 6, expand the quantity of the fucoidan oligosaccharide with fixed structure, and then the use scope of fucoidan oligosaccharide is expanded, more Component Sources are provided to prevent or treating the drug of atopic dermatitis and eczema, alimentary infection.

Description

Fucoidan oligosaccharide and the preparation method and application thereof
Technical field
Present invention relates particularly to fucoidan oligosaccharides and the preparation method and application thereof.
Background technique
Fucoidin is a kind of brown alga heteroglycan of sulphation, bioactivity have broad spectrum activity [Fitton, J.H., Stringer,D.N.,and Karpiniec,S.S.(2015).Therapies from Fucoidan:An Update.Marin Drugs 13,5920-5946.].However, due to polysaccharide formulation has heterogeneous and polysaccharide formulation cannot be by Standardization, is medically practically impossible to using polymer molecule.Therefore, how to extract to have from fucoidin and fix The oligosaccharide of structure and standard feature is just at a problem.The depolymerisation of fucoidin is realized using enzyme and extraction is provided There is bioactivity oligosaccharide, provides new possibility using this kind of compound in pharmacy and lift face shaping for it [Kusaykin,M.I.,Silchenko,A.S.,Zakharenko,A.M.,and Zvyagintseva,T.N.(2016) .Fucoidanases.Glycobiology 26,3-12]。
Fucoidan oligosaccharide is used, in the mixture for preventing or treating atopic dermatitis and eczema The saying of [RU2586776 C2, on June 10th, 2016], alimentary infection [WO2016139333 A1, on September 9th, 2016] is Through being published.It has been proposed that using N- fucoidan oligosaccharide stimulation blood vessel [RU 2559629 C2,2015 On August 10 ,], and using sulfated oligosaccharides derivative as efficient heparin-binding protein inhibitor [RU 2483074C2, On May 27th, 2013] be subject to using.It has been learnt that, fucosylation oligosaccharide can be used for protecting the plants from the evil of pathogen [US 6984630 B1,10.01.2006].
Compared with multi-step takes the method extracting sulfuric acid oligosaccharide of organic synthesis, pass through enzyme preparation from fucoidin The step of producing being unique in that for similar oligosaccharide: more simple possible, producing oligosaccharide in quantity for it is less, obtain The reaction product yield arrived is higher.
Initially, what the hydrolysis that we pass through enzyme was got from withered bladder-wrack (Fucus evanescens) is rock algae Polysaccharide oligomerization sugar.To reach this as a result, we are micro- fucoidin and from the ocean Formosa algae (Formosa algae) The primary fucoidin FFA obtained in biology is mixed, and is put into 0.015M sodium phosphate buffer, pH value 7.2, and 25 DEG C temperature environment manually cultivate 72h.Macromolecule hydrolysis product, 10,000g centrifugations are settled out with 75% ethanol water Supernatant is placed in rotary evaporator and is evaporated concentration by 30min, and distilled water pours into supernatant containing P-6 after redissolving In biogel column, then watering balance elutes fucosylation oligosaccharide with the rate of 0.7mL/min.Low molecular weight Oligosaccharide is put together, and concentration and again chromatographic isolation are carried out in rotary evaporator.As a result, what is generally yielded is knot Structure is disaccharides [Xi Erqinke A.C., Formosa algae marine microorganism KMM 3553T and the sea mollusk spider of A and B Fucoidin and algin catenase in spiral shell: chemical candidate doctor's degree reply paper.Russian national academy of sciences Far East branch Pacific Ocean Bioorganic Chemistry research institute, Vladivostok, 2014, page 69].But structure is the disaccharides of A and B, It is limited to the value volume and range of product of fucosyl residues in molecule, application range is smaller.
Summary of the invention
For above-mentioned the technical problems existing in the prior art, the object of the present invention is to provide a kind of sulfated fucans Ester oligosaccharide, the quantity of the fucosyl residues (fixed structure) in the fucoidan oligosaccharide are 4 or 6, are expanded The quantity of fucoidan oligosaccharide with fixed structure.
It is a further object to provide the preparation methods of above-mentioned fucoidan oligosaccharide.This method is benefit Fucoidan oligosaccharide, more simple possible are produced in Sargassum horneri fucoidin solution with enzyme preparation, reaction product obtains Rate is higher.
Third object of the present invention is to provide the applications of above-mentioned fucoidan oligosaccharide.
In order to solve the above technical problems, the technical solution of the present invention is as follows:
A kind of fucoidan oligosaccharide, including the chain being connected in sequence by four fucosyl residues, fucose By 1 → 3 and 1 → 4 chemical combination alternately occurs for residue, and sulfate is distributed in the C of the second fucosyl residues2And C3On and third rock algae The C of saccharide residue2On.
Preferably, above-mentioned fucoidan oligosaccharide further includes side chain, side chain by two kinds of non sulphates fucose Residue is formed by 1 → 2 glucosides key connection, and side chain is by 1 → 4 glucosides key connection on third fucosyl residues.
Preferably, the fucoidan oligosaccharide is selected from following two:
The preparation method of above-mentioned fucoidan oligosaccharide, includes the following steps:
Recombination fucoidanase FFA1 and Sargassum horneri fucoidin solution are mixed in Tris-HCl buffer, mixed Liquid, insulation reaction, heating enzyme deactivation, separation, obtains the fucoidan oligosaccharide of molecular formula I and II.
Someone can produce out recombination fucoidanase FFA1 [Xi Erqinke A.C., Fu Er by other known method The fucoidin and algin catenase to rub in husky algae marine microorganism KMM 3553T and sea mollusk spider spiral shell: change Learn candidate doctor's degree reply paper.Russian national academy of sciences Far East branch Pacific Ocean Bioorganic Chemistry research institute, Fu Ladi Fertile stoke, 2014, page 110].
Preferably, the pH value of the Tris-HCl buffer is 7.0-7.5.
Preferably, the mass ratio of the recombination fucoidanase FFA1 and Sargassum horneri fucoidin is 0.01%-0.03%.
Preferably, the method for the cultivation is within the temperature range of 25 DEG C -38 DEG C, to cultivate 72-75h.
Preferably, the temperature of the heating enzyme deactivation is 95-105 DEG C, heating time 5-10min.
Preferably, wherein the separating step includes the steps that precipitating macromolecular hydrolysate, the precipitating with precipitating reagent Agent is 75% ethanol water or 75% aqueous acetone solution.
It is further preferred that the separating step further includes that will precipitate the sediment centrifugation that macromolecular hydrolysate obtains to mention The step of taking.
Still more preferably, the condition that the centrifugation is extracted are as follows: 9000-10000g, centrifugation time 20-30min.
Preferably, the separating step includes that the supernatant liquor after extraction sediment is poured into anion exchange absorbing column In, carry out gradient elution the step of.
It is further preferred that in the anion exchange absorbing column, using ammonium hydrogen carbonate as eluant, eluent, with 1ml/min Elution speed carry out gradient elution.
The fucoidan oligosaccharide or its officinal salt are as fucoidanase, fucosidase and sulfuric acid Application in the matrix of esterase.
The fucoidan oligosaccharide or its officinal salt preparation for prevent or treat atopic dermatitis and Eczema, alimentary infection drug in application.
A kind of pharmaceutical composition, it includes the above-mentioned fucoidan oligosaccharide of therapeutically effective amount or its is pharmaceutically acceptable Salt.
Preferably, aforementioned pharmaceutical compositions further include pharmaceutical acceptable carrier.
The invention has the benefit that
The quantity of fucosyl residues (fixed structure) in fucoidan oligosaccharide provided in the present invention is 4 Or 6, the quantity of the fucoidan oligosaccharide with fixed structure is expanded, and then expand fucoidan The use scope of oligosaccharide provides more groups to prevent or treating the drug of atopic dermatitis and eczema, alimentary infection Divide source.
Two kinds of fucoidan oligosaccharides can be prepared using method of the invention, enrich sulfated fucan The type of ester oligosaccharide.The yield of this method simple possible, reaction product is higher.
Specific embodiment
The present invention is further explained in the light of specific embodiments.
Embodiment 1
Recombination fucoidanase FFA1 (1mg) be put into pH value be 7.2 Tris-HCl buffer in and 5% Sargassum horneri (Sargassum horneri) fucoidin solution mixes, people's work culture in 37 DEG C of temperature by mixture 72h is then heated to 100 DEG C, heating time 5min.The sediment of generation is separated and is discarded with centrifugal process.Upper Ethyl alcohol is added in layer clear liquid, until its concentration reaches 75%.Sediment (macromolecule component) centrifugal treating of formation, 9000g, from Heart time 20min.Supernatant liquor (low molecular composition) is poured into the cylinder containing Q- Ago-Gel adsorbent, uses pure water Balance.Then with the speed of 1mL/min, linear gradient elution is carried out to oligosaccharide with ammonium hydrogen carbonate.First operation obtains molecular formula For the sulphation fucosylation oligosaccharide of II, then operation obtains the sulphation fucosylation oligosaccharide that molecular formula is I, with Obtained product is freeze-dried afterwards, the yield of obtained target product accounts for the 5-15% of low molecular composition total amount.
Embodiment 2
Recombination fucoidanase FFA1 (1mg) be put into pH value be 7.2 Tris-HCl buffer in and 10% Sargassum horneri (Sargassum horneri) fucoidin solution mixes, people's work culture in 37 DEG C of temperature by mixture 75h is then heated to 100 DEG C, heating time 10min.The sediment of generation is separated and is discarded with centrifugal process.Upper Acetone is added in layer clear liquid, until its concentration reaches 75%.The sediment (macromolecule component) of formation is subject to centrifugal treating, 10000g, centrifugation time 30min.Supernatant liquor (low molecular composition) is poured into the cylinder containing Q- Ago-Gel adsorbent In, use pure water equilibrium.Then with the speed of 1mL/min, linear gradient elution is carried out to oligosaccharide with ammonium hydrogen carbonate.First operate The fucoidan oligosaccharide for being II to molecular formula, then it is oligomeric to obtain the fucoidan that molecular formula is I for operation Sugar is then freeze-dried obtained product, and the yield of obtained target product accounts for the 7-20% of low molecular composition total amount.
The structure of obtained oligosaccharide is determined with NMR spectrum.
In the oligosaccharide that molecular formula is I1H- is spectrally, it has been found that four different Alpha-Methyl-L- rock algae pyrans Chemical shift has occurred in glucoside residue, this four residues are indicated with letter a-d respectively in table 1.By 1DTOXY spectrum With COSY spectrum, chemical shift and their chemical sequence that each residue occurs can be determined.From HSQC- spectrum In can determine1H chemical shift and13Relationship between C chemical shift.ROESY spectrum shows in d residue H1 and c residue H4 Between, between c residue H1 and a residue H3, there is relevance between b residue H1 and H3 residue and d residue H4.In HMBC spectrum On, it is observed that between d residue С 1 and c residue H4, between c residue С 1 and a residue H3, b residue С 1 and d residue H3 Between have relevance.Similarly, proton d1, c1 and b1 correspondingly have relevance with carbon atom c4, a3 and d3 respectively.
On this basis it may be concluded that the oligosaccharide that molecular formula is I has a carbon skeleton: α-L-Fucp-1 → 3- α- L-Fucp-1→4-α-L-Fucp-1→3-α-L-Fucp。
1 molecular formula of table is the chemical shift (ppm) of the fucosylation oligosaccharide of I
Residue H1 H2 H3 H4 H5 H6
a 5.50 4.54 4.06 4.09 4.24 1.24
b 5.39 4.58 4.72 4.22 4.59 1.26
c 5.37 4.65 4.76 4.27 4.57 1.41
d 5.30 4.59 4.20 4.12 4.44 1.30
C1 C2 C3 C4 C5 C6
a 91.74 74.62 74.99 70.40 67.12 16.65
b 95.86 73.61 76.33 71.81 67.74 16.44
c 96.32 73.68 75.16 80.54 69.07 16.85
d 99.93 74.62 74.49 70.62 68.28 16.51
Under the conditions of 700 megahertzs, 308K1The chemical shift of H spectrum, acetone 2.225 can measure various chemistry Displacement.Under the conditions of 700 megahertzs, 308K13The chemical shift of С spectrum, acetone 31.45 can measure various chemical potentials It moves.
By same mode, it can determine that molecular formula is the structure of the oligosaccharide of II.1H- spectrum shows that there are six The different monosaccharide residue of kind.1DTOXY spectrum, COSY spectrum and HSQC spectrum can determine, the matter of each monosaccharide residue Sub- chemical shift and carbon chemical shifts.These monosaccharide residues are all embodied in chart 2.
In ROESY spectrally it is observed that in a ' between residue H1 and d ' residue H4, in e ' residue H1 and d ' residue H3 Between, between d ' residue H1 and c ' residue H4, between c ' residue H1 and b ' residue H3, f ' residue H1 and a ' residue H2 it Between, all there is correlation.HMBC spectrally, carbon atom a ' 1, d ' 1, e ' 1, f ' 1, c ' 1 respectively with proton d ' 4, c ' 4, d ' 3, A ' 2 and b ' 3 has correlation, and proton a ' 1, e ' 1, f ' 1, d ' 1 is then respectively provided with phase with carbon atom d ' 4, d ' 3, a ' 2, c ' 4 Guan Xing.In addition, in HMBC spectrally it is observed that carbon atom b ' 3 and proton c ' 1 or d ' 1 has correlation.
2 molecular formula of table is the chemical shift (ppm) of the fucosylation oligosaccharide of II
Under the conditions of 700 megahertzs, 308K1The chemical shift of H spectrum, acetone 2.225 can measure various chemistry Displacement.Under the conditions of 700 megahertzs, 308K13The chemical shift of С spectrum, acetone 31.45 can measure various chemical potentials It moves.
Based on discussed above it can be concluded that molecular formula is that the oligosaccharide of II has the branched structure of following form:
Position of the sulfate in monosaccharide residue, can by by its proton displacement and fucose (H1=5,19, H2= 3,76, H3=3,85, H4=3,80, H5=4,19, H6=1,20) it compares and is determined, it can also be by former by its carbon Son displacement with Alpha-Methyl-L- rock algae pyranoside (C1=100,5, C2=69,0, С 3=70,6, С 4=72,9, С 5=67, 5, С 6=16,5) it compares and is determined.Movement and Alpha-Methyl-L- rock according to fucose H2 in feeble field 0.8-0.9ppm Algae pyranoside feeble field 4-6ppm movement, it can be calculated that sulfation has occurred in position 2.According to H3 weak Movement of the movement and C3 of field 0.9-1.0ppm in feeble field 4-6ppm can determine that there are sulfate in position 3.
Above-mentioned, although specific embodiments of the present invention have been described, the limitation not to invention protection scope, Those skilled in the art should understand that based on the technical solutions of the present invention, those skilled in the art do not need to pay The various modifications or changes that creative work can be made are still within the scope of the present invention.

Claims (5)

1. the preparation method of sulfated fucan oligosaccharide, characterized by the following steps:
Recombination fucoidanase FFA1 and Sargassum horneri fucoidin solution are mixed in Tris-HCl buffer, obtain mixed liquor, Insulation reaction, heating enzyme deactivation, separation, obtain the fucoidan oligosaccharide of molecular formula I and II;
2. preparation method according to claim 1, it is characterised in that: wherein the separating step includes being precipitated with precipitating reagent The step of macromolecular hydrolysate, the precipitating reagent are 75% ethanol water or 75% aqueous acetone solution.
3. preparation method according to claim 1, it is characterised in that: the separating step further includes that will precipitate macromolecular water The step of sediment centrifugation that solution product obtains is extracted.
4. preparation method according to claim 3, it is characterised in that: the separating step includes after extracting sediment The step of supernatant liquor pours into anion exchange absorbing column, carries out gradient elution.
5. the fucoidan oligosaccharide of the molecular formula II of any preparation method preparation of claim 1-3 or its can medicine Use application of the salt in the matrix as fucoidanase, fucosidase and sulfatase.
CN201611258163.5A 2016-12-30 2016-12-30 Fucoidan oligosaccharide and the preparation method and application thereof Active CN106749439B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201611258163.5A CN106749439B (en) 2016-12-30 2016-12-30 Fucoidan oligosaccharide and the preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611258163.5A CN106749439B (en) 2016-12-30 2016-12-30 Fucoidan oligosaccharide and the preparation method and application thereof

Publications (2)

Publication Number Publication Date
CN106749439A CN106749439A (en) 2017-05-31
CN106749439B true CN106749439B (en) 2019-09-17

Family

ID=58954631

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201611258163.5A Active CN106749439B (en) 2016-12-30 2016-12-30 Fucoidan oligosaccharide and the preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN106749439B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109055460B (en) * 2018-09-13 2021-06-29 青岛创通生物科技有限公司 Low molecular weight fucoidin and application thereof in preparing cosmetics
CN110772498A (en) * 2019-09-09 2020-02-11 山东省科学院生物研究所 Preparation method of novel fucoxanthin-loaded fucoidan sulfate nanoparticles

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102234336A (en) * 2010-04-24 2011-11-09 中国科学院海洋研究所 Fucoidan-galactosan sulfate, extracting, separating, and purifying method thereof, and application thereof
CN104523744A (en) * 2015-01-14 2015-04-22 青岛海洋生物医药研究院股份有限公司 Fucan sulfate and application of low-molecular-weight fucan sulfate in preparation of blood fat reduction and weight loss drugs and health care products
CN105001348A (en) * 2015-07-13 2015-10-28 江南大学 Extraction method for fucoidin with high yield and high ratio of fucose
CN105399848A (en) * 2015-11-20 2016-03-16 中国科学院上海药物研究所 Fucosan sulfate as well as preparation method and application of fucosan sulfate

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102234336A (en) * 2010-04-24 2011-11-09 中国科学院海洋研究所 Fucoidan-galactosan sulfate, extracting, separating, and purifying method thereof, and application thereof
CN104523744A (en) * 2015-01-14 2015-04-22 青岛海洋生物医药研究院股份有限公司 Fucan sulfate and application of low-molecular-weight fucan sulfate in preparation of blood fat reduction and weight loss drugs and health care products
CN105001348A (en) * 2015-07-13 2015-10-28 江南大学 Extraction method for fucoidin with high yield and high ratio of fucose
CN105399848A (en) * 2015-11-20 2016-03-16 中国科学院上海药物研究所 Fucosan sulfate as well as preparation method and application of fucosan sulfate

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Isolation and Culture of a Marine Bacterium Degrading the Sulfated Fucans from Marine Brown Algae;Valérie Descamps,等;《MARINE BIOTECHNOLOGY》;20051016;第8卷;27-39 *

Also Published As

Publication number Publication date
CN106749439A (en) 2017-05-31

Similar Documents

Publication Publication Date Title
Usoltseva et al. Structural characteristics and anticancer activity in vitro of fucoidan from brown alga Padina boryana
Yuan et al. Isolation, structures and biological activities of polysaccharides from Chlorella: A review
Chi et al. Ulvan lyase assisted structural characterization of ulvan from Ulva pertusa and its antiviral activity against vesicular stomatitis virus
Liu et al. Characterization and antitumor activity of a polysaccharide from Strongylocentrotus nudus eggs
Siu et al. Molecular properties and antioxidant activities of polysaccharides isolated from alkaline extract of wild Armillaria ostoyae mushrooms
Zhu et al. Comparison and structural characterization of polysaccharides from natural and artificial Se-enriched green tea
Usoltseva et al. Structure and anticancer activity of native and modified polysaccharides from brown alga Dictyota dichotoma
Jeff et al. Purification and in vitro anti-proliferative effect of novel neutral polysaccharides from Lentinus edodes
Zheng et al. Structural characterization of a polysaccharide from Chrysanthemum morifolium flowers and its antioxidant activity
Ru et al. Structural characterization, hypoglycemic effects and mechanism of a novel polysaccharide from Tetrastigma hemsleyanum Diels et Gilg
Menshova et al. Structure and anticancer activity in vitro of sulfated galactofucan from brown alga Alaria angusta
Kono et al. NMR spectroscopic structural characterization of a water-soluble β-(1→ 3, 1→ 6)-glucan from Aureobasidium pullulans
Yu et al. Structural study of fucoidan from sea cucumber Acaudina molpadioides: A fucoidan containing novel tetrafucose repeating unit
Sun et al. Anti-inflammatory activity and structural identification of a sulfated polysaccharide CLGP4 from Caulerpa lentillifera
Shevchenko et al. Further studies on structure of fucoidan from brown alga Saccharina gurjanovae
Hu et al. Identification of a highly sulfated fucoidan from sea cucumber Pearsonothuria graeffei with well-repeated tetrasaccharides units
Zheng et al. Structural elucidation of a polysaccharide from Chrysanthemum morifolium flowers with anti-angiogenic activity
Wang et al. A heteropolysaccharide, l-fuco-d-manno-1, 6-α-d-galactan extracted from Grifola frondosa and antiangiogenic activity of its sulfated derivative
Ye et al. Structural elucidation of the polysaccharide moiety of a glycopeptide (GLPCW-II) from Ganoderma lucidum fruiting bodies
Ye et al. Structural characterisation and anti-ageing activity of extracellular polysaccharide from a strain of Lachnum sp.
Chan et al. Structural analysis of water-soluble polysaccharides isolated from Panax notoginseng
He et al. Structure elucidation and antioxidant activity of a novel polysaccharide from Polyporus umbellatus sclerotia
Cai et al. Structural characterization, and in vitro immunostimulatory and antitumor activity of an acid polysaccharide from Spirulina platensis
Redgwell et al. Cell wall polysaccharides of Chinese Wolfberry (Lycium barbarum): Part 1. Characterisation of soluble and insoluble polymer fractions
Karelin et al. Synthesis of oligosaccharides related to cell wall polysaccharides of the fungi Candida and Aspergillus

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant